Skip to content
Rameda Pharma
Rameda Pharma
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact
Corporate Website
  • ع
  • IR Library
    • Results Center
    • Presentations and Publications
    • Board and Shareholders Actions
    • Our People
  • Share & Corporate Information
    • Key Information
    • Listing Information
    • Analyst Coverage
  • News and Disclosures
    • Corporate News
    • Regulatory Disclosures
  • IR Calendar
  • Corporate Governance
    • BOD Reports
    • Corporate Governance Reports
  • IR Contact

Yearly Archives: 2022

You are here:
  1. Home
  2. 2022

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminAugust 14, 2022

EGX Disclosure on BOD and shareholding structure

Regulatory DisclosuresBy adminJune 21, 2022

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. joins the UN Global Compact, the world’s largest corporate sustainability initiative.

Corporate NewsBy adminJune 20, 2022

Disclosure to the EGX regarding UN Global Compact membership

Regulatory DisclosuresBy adminJune 20, 2022

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. commences the production of antiviral COVID-19 treatment, Molnupiravir Rameda

Corporate NewsBy adminJune 17, 2022

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. acquires a fast-growing anticonvulsant which grew at 2019-21 CAGR of 226%

Corporate NewsBy adminJune 15, 2022

Disclosure to EGX regarding molecule acquisition

Regulatory DisclosuresBy adminJune 15, 2022

Disclosure to EGX on BOD minutes

Regulatory DisclosuresBy adminMay 31, 2022

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. acquires fast-growing molecule with an established market presence

Corporate NewsBy adminMay 23, 2022

Disclosure to EGX regarding molecule acquisition

Regulatory DisclosuresBy adminMay 23, 2022
←1
2
…34567…
8
9→

All Rights Reserved © 2024

Go to Top